Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 1801.T
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Positive
83%
Leverage & Liquidity Weak
17%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio -2.61 1.25 1.29
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -71.10 -4.43 15.35
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 9.77 5024.25 4576.99
Cash 125.88 2371.57 1049.92
Capex 0.00 0.00 0.00
Free Cash Flow inf 0.00 34.77
Revenue 52.52 3344.87 2193.00
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin -7.29 0.07 0.07
Operating Margin 30.44 0.01 0.01
ROA 244.61 < 0.005 < 0.005
ROE 284.88 0.02 < 0.005
ROIC 90.24 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 1801.T is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 1801.T is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 1801.T is permitted for members.